We are proud to announce that OZ Biosciences has been recognized as a key innovator in the EU-funded Research & Innovation project, cmRNAbone!
Our innovation, titled “Novel gene vectors and formulations for delivery of cmRNA in 3D matrix” has been published on the Innovation Radar’s public website.
After four and a half years of intensive research, the cmRNAbone project came to a successful conclusion and concluded its activities in June 2024. The consortium managed to demonstrate that delivery and expression of chemically modified mRNA into bone defects is possible, and provided efficacy data.
Beyond cmRNAbone, OZ Biosciences has developed other groundbreaking innovations, including:
- NanOZ-LNP (Lipid NanoParticles): new ionizable lipids for lnp formulation.
- Magnetofection™ Technology: magnetic assisted transfection.
- Viral Enhancer: novel patented chemical composition that increases viral infection.
- Polyfection Technology: polymer-based transfection.
A huge thank you to the projects team cmRNAbone.
The cmRNAbone project Our mRNA catalog
Related Articles
Welcome to SINPAIN partners in Marseille
Revolutionizing Knee Arthritis Treatment: The SINPAIN Research Project
